Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to ...

Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.

The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...

Medically reviewed by Marla Anderson, MD Key Takeaways Triple-negative breast cancer is aggressive and often resists ...

The sBLA is supported by results from the pivotal phase 3 TROPION-Breast02 clinical trial (NCT05374512), which evaluated the ...

Add Yahoo as a preferred source to see more of our stories on Google. Friends, have you heard of triple-negative breast cancer [TNBC]? It’s a particularly aggressive type of breast cancer that can ...

Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

A new study found that the degree of immune enrichment predicted radiosensitivity. The radiosensitivity index (RSI), a validated genomic marker, was higher in pretreatment immune-enriched ...

Clinton Yam, MD, reflects on the guidance that he received from an important mentor he had during his fellowship, Dr Stacy Moulder. Dr Yam recalls his mentor's strong advocacy and personalized ...